Dietrich Stephan

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article reads like a press release or a news article and may be largely based on routine coverage. Please help improve this article and add independent sources. (April 2019) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (October 2021) (Learn how and when to remove this message) (Learn how and when to remove this message)

Dietrich A. Stephan
Born	(1969-08-25) August 25, 1969 (age 55) Pittsburgh, Pennsylvania
Nationality	American
Occupation(s)	Scientist and Entrepreneur
Known for	Founder/co-Founder of NeuBase Therapeutics, Navigenics, Amnestix, Aueon, Pendulum Therapeutics, Peptilogics

Dietrich A. Stephan (born August 25, 1969) is an American human geneticist and entrepreneur who works in personalized medicine. Stephan is currently CEO of NeuBase Therapeutics^[1] and a General Partner in Cyto Ventures. Before NeuBase, Stephan was CEO of LifeX^[2] and Chairman and Professor of Human Genetics at the University of Pittsburgh. Prior, he was founding Chairman of the Neurogenomics Division at the Translational Genomics Research Institute. Stephan has founded or co-founded 14 biotechnology companies and advised many others. Stephan was co-founder of Navigenics,^[3] a personal genetics company.